Procurement in 21st century in the chemical, pharmaceutical and healthcare industry

Procurement in 21st century in the chemical, pharmaceutical and healthcare industry

Most companies in the Chemical, Pharmaceutical and Healthcare industry have a procurement performance below average, which in turn means a disadvantage compared to other industries. These companies are not able to realize their existing cost reduction potentials in procurement. Additional short term...

Verfasser:	Makowski, Thorsten ^GND Clauß, Michael
FB/Einrichtung:	FB 12: Chemie und Pharmazie
Dokumenttypen:	Artikel
Medientypen:	Text
Erscheinungsdatum:	2011
Publikation in MIAMI:	06.08.2012
Datum der letzten Änderung:	18.03.2016
Quelle:	Journal of Business Chemistry, 8 (2011) 3, S. 123-132
Angaben zur Ausgabe:	[Electronic ed.]
Fachgebiet (DDC):	330: Wirtschaft
Lizenz:	InC 1.0
Sprache:	English
Anmerkungen:	Section "Practicioner’s Section"
Format:	PDF-Dokument
URN:	urn:nbn:de:hbz:6-69379464849
Permalink:	https://nbn-resolving.de/urn:nbn:de:hbz:6-69379464849
Onlinezugriff:	2011_vol-8_iss3_123-132.pdf

Journal of Business Chemistry

1 (2004) 1, S. 2-13: Enhancing market-oriented R&D planning by integrated market and patent portfoli...
1 (2004) 1, S. 14-20: Intellectual capital and competitive advantages the case of TTY Biopharm Compa...
1 (2004) 1, S. 21-24: Accelerating the processes of innovation Degussa's new bonus system creates in...
1 (2004) 2, S. 22-36: Organising product stewardship in large chemical companies
1 (2004) 2, S. 37-47: Virtual communities as an organizational mechanism for embedding knowledge in ...
1 (2004) 2, S. 48-53: The human side of innovation
2 (2005) 1, S. 1-3: Why are scientists not managers!? the importance of interdisciplinary skills in ...
2 (2005) 1, S. 4-18: Condiment paprika research in Australia
2 (2005) 1, S. 19-36: Chemicals regulation and the Porter Hypothesis a critical review of the new Eu...
2 (2005) 1, S. 37-53: Futuring in the European chemical industry
2 (2005) 2, S. 54: Defining "Business Chemistry"
2 (2005) 2, S. 55-70: Internationalisation of SMEs a micro-economic approach
2 (2005) 2, S. 71-89: "Sensory Fit Panel" – Development of a new Advertising Claim Support method ...
2 (2005) 2, S. 90-96: High-Performance research for High-tech materials 1. Degussa’s Science-to-Bu...
2 (2005) 3, S. 97-98: Trends in biotechnology opportunities and threats for developing countries!?
2 (2005) 3, S. 99-106: Different rhythms of health biotechnology development in Brazil and Cuba
2 (2005) 3, S. 107-111: Streptomyces as a host for the secretion of heterologous proteins for the pr...
2 (2005) 3, S. 112-118: Science and society in Cuba in the context of techno-economic globalization
2 (2005) 3, S. 119-125: Propolis patents and technology trends for health applications
2 (2005) 3, S. 126-137: Future studies in Brazil CGEE approach for bio- and nanotechnology
3 (2006) 1, S. 1: End of an Era? the chemical industries’ future
3 (2006) 1, S. 2-12: The global business of chemistry prospects and challenges
3 (2006) 1, S. 13-21: Systematically creating coincidental product evolution case studies of the app...
3 (2006) 1, S. 22-41: The consumption of Sicilian red oranges implications for firms involved in com...
3 (2006) 1, S. 42-48: Intellectual property an underestimated and undermanaged asset?
3 (2006) 2, S. 1: Interdisciplinarity at Work
3 (2006) 2, S. 3-5: School for the bilingual dual master’s degrees in business and biotech
3 (2006) 2, S. 7-14: How do Italian biotechnology startups survive?
3 (2006) 2, S. 15-30: Detergent phosphates an EU policy assessment
3 (2006) 2, S. 31-38: Chemische Fabrik Griesheim – pioneer of electrochemistry
3 (2006) 3, S. 1: Changes in the chemical industry
3 (2006) 3, S. 3-8: Dialogue on nanotech the South Carolina Citizens’ School of Nanotechnology
3 (2006) 3, S. 9-25: Innovation strategies for the Australian chemical industry
3 (2006) 3, S. 27-41: Three-dimensional valuation of IP rights
3 (2006) 3, S. 43-47: The future belongs to renewable resources
4 (2007) 1, S. 1: Struggling for profitability not necessarily new, but challenging
4 (2007) 1, S. 3-10: Commentary CeNTech nanotechnological research and application
4 (2007) 1, S. 11-19: Open innovation the new way of knowledge transfer?
4 (2007) 1, S. 21-32: A model of knowledge sharing in biomedical engineering challenges and requirem...
4 (2007) 1, S. 33-39: Value pricing in the chemical industry most powerful lever to profitability
4 (2007) 2, S. 40: Tackling present and future challenges of the chemical industry
4 (2007) 2, S. 42-44: Australian cooperative business
4 (2007) 2, S. 46-58: Knowledge management and knowledge-based marketing
4 (2007) 2, S. 60-75: Engineering an instrument to evaluate safety critical manning arrangements in ...
4 (2007) 2, S. 76-86: Technology to clean up coal for the post-oil era
4 (2007) 3, S. 88: Exploring the wide field of business chemistry
4 (2007) 3, S. 90-95: Channel management in the chemical industry selecting the right option
4 (2007) 3, S. 96-114: Testing costs and testing capacity according to the REACH requirements result...
4 (2007) 3, S. 116-126: Enthalpy change firing enthusiasm for learning
4 (2007) 3, S. 128-136: Chemical plant engineering projects customers around the world prefer cuttin...
5 (2008) 1, S. 1-3: The Journal of Business Chemistry five issues of covering the latest trends in r...
5 (2008) 1, S. 5-6: REACh a European chemicals regulation with global intersectoral consequences
5 (2008) 1, S. 7-22: Patterns of collaboration along the bio-pharmaceutical innovation process
5 (2008) 1, S. 23-38: The spatial dynamics of the European biotech industry a NEG approach with vert...
5 (2008) 1, S. 39-43: The growing importance of covering payment risks in the chemical industry
5 (2008) 2, S. 44: Developments at the outposts of the chemical industry
5 (2008) 2, S. 46-47: REACh due diligence – Extended scope of M&A services in the framework of REA...
5 (2008) 2, S. 48-63: Entrepreneurial potential in chemistry and pharmacy results from a large surve...
5 (2008) 2, S. 64-68: A motor for future-proof jobs the results of the study "Biotechnology in Germa...
5 (2008) 2, S. 70-78: Unbiased insight on biopharma’s innovation crisis
5 (2008) 3, S. 79: Dark clouds are gathering
5 (2008) 3, S. 81-82: Sector inquiry into the pharmaceutical sector
5 (2008) 3, S. 83-93: The value based portfoliomanagement in response to REACh a manual of different...
5 (2008) 3, S. 101-105: Managing the effects of the business cycle in the chemical industry
6 (2009) 1, S. 1-2: Discussing challenges in the chemical industry for five years
6 (2009) 1, S. 3-6: The effects of the financial crisis on the future of the chemical industry
6 (2009) 1, S. 7-9: Mergers & Acquisitions (M&A) in the Pharmaceutical and Chemical Industries: A Li...
6 (2009) 1, S. 11-30: Open source biopharmaceutical innovation a mode of entry for firms in emerging...
6 (2009) 1, S. 31-41: Biotechnology research in South Africa a benchmarking exercise
6 (2009) 1, S. 43-54: REACH effects – opportunities and risks for transfer pricing
6 (2009) 2, S. 55-56: Thunderstorms strike the economy
6 (2009) 2, S. 57-63: The place of chemistry in business
6 (2009) 2, S. 65-67: Chemists of the future
6 (2009) 2, S. 69-87: REACH and the role of stakeholders in its socio-economic analysis
6 (2009) 2, S. 89-96: Patent license negotiation best practices
6 (2009) 2, S. 97-105: M&A since Y2K - an overview of chemicals deals invilving BRIC countries in th...
6 (2009) 3, S. 106: Preparing for the time after the crisis
6 (2009) 3, S. 108-110: A capital market's view on Industrial Biotechnology proper valuation is the ...
6 (2009) 3, S. 112-125: Assessment of thermal-stable polymer nanocomposite techniques by patent cita...
6 (2009) 3, S. 126-136: Feasibility of Active Ingredient (AI) development for new biocides in the EU
6 (2009) 3, S. 138-146: How to implement ‘access to medicine’ AND enhance economic performance b...
7 (2010) 1, S. 1: Tiny things being huge
7 (2010) 1, S. 3-13: Nanotechnology patenting in China and Germany a comparison of patent landscapes...
7 (2010) 1, S. 15-30: Identifiyng the emerging roles of nanoparticles in biosensors
7 (2010) 1, S. 31-45: Knowledge sharing in heterogeneous collaborations a longitudinal investigation...
7 (2010) 2, S. 67-68: Mergers & acquisitions (M&A) in the pharmaceutical industry the wheel keeps on...
7 (2010) 2, S. 69-79: New biocide active substances needs and challenges in the EU as viewed by indu...
7 (2010) 2, S. 81-88: REACH implementation costs in the Belgian food industry a semi-qualitative stu...
7 (2010) 2, S. 89-96: Performance improvement in pharmaceutical R&D through new outsourcing models
7 (2010) 2, S. 97-106: Sustainability in the chemical and pharmaceutical industry results of a bench...
7 (2010) 3, S. 109-115: Bio products from bio refineries trends, challenges and opportunities
7 (2010) 3, S. 117-130: Analyzing the Direct Methanol Fuel Cell technology in portable applications ...
7 (2010) 3, S. 131-153: Multidisciplinary collaborations in pharmaceutical innovation a two case-stu...
7 (2010) 3, S. 155-163: Pharma 3.0 delivering on health outcomes
8 (2011) 1, S. 3-4: Industrial biotechnology becomes a key competitive factor
8 (2011) 1, S. 5-16: Towards a phenotype of the amphibious company an illustrative case from the che...
8 (2011) 1, S. 17-33: Exploring market knowledge in product development of chemical firms
8 (2011) 1, S. 35-45: Pricing in the crisis? an empirical analysis
8 (2011) 2, S. 49-63: Optimal ambidexterity and exploration valuableness balancing short-term and lo...
8 (2011) 2, S. 65-74: The challenges and opportunities of the European Union leadmarket initiative c...
8 (2011) 2, S. 75-86: Sources of information for technology intelligence in chemical formulation
8 (2011) 2, S. 87-98: Working capital management in the Swiss chemical industry
8 (2011) 3, S. 101-113: R&D Spin-outs in the pharmaceutical industry
8 (2011) 3, S. 115-122: Supply-side determinants of Energy Consumption and Efficiency (ECE) innovati...
8 (2011) 3, S. 123-132: Procurement in 21st century in the chemical, pharmaceutical and healthcare i...
8 (2011) 3, S. 133-146: Application of timing option to founding investment decision of biotech star...
9 (2012) 1, S. 3-18: Startup of new plants and process technology in the process industries organizi...
9 (2012) 1, S. 19-30: The founding angels investment model case studies from the field of nanotechno...
9 (2012) 1, S. 31-48: Standardized cost estimation for new technologies (SCENT) methodology and tool
9 (2012) 1, S. 49-62: Development of an effective outsourcing strategy for toxicological studies in ...
9 (2012) 2, S. 65-66: The future of chemical distribution in Europe customer relations as key value ...
9 (2012) 2, S. 67-84: Collaborative development of new process technology/equipment in the process i...
9 (2012) 2, S. 85-104: Opportunities for- and configuration of foreign innovation a case study of mu...
9 (2012) 2, S. 105-113: Chemical distribution in Belgium from 2007 to 2010 an empirical study
9 (2012) 3, S. 117-131: Open innovation and firm performance in small-sized R&D active companies in ...
9 (2012) 3, S. 133-146: Research inequality in nanomedicine
9 (2012) 3, S. 147-160: Morphological Analysis of technologies using multidimensional scaling
9 (2012) 3, S. 161-166: IP strategies in business operations with China
10 (2013) 1, S. 3-21: Management of technology licensing as a foreign market entry mode the case of ...
10 (2013) 1, S. 23-34: The influence of the global crisis on the management of the small firms activ...
10 (2013) 1, S. 35-48: Development of integrated production networks using extended material flow an...
10 (2013) 1, S. 49-56: Personalised medicine, unmet need or business strategy?
10 (2013) 2, S. 59-66: Challenges and strategies for chemical/industrial parks in Europe
10 (2013) 2, S. 67-87: Inter-industry innovations in terms of electric mobility Should firms take a ...
10 (2013) 2, S. 89-98: Are you still comparing or already learning? experience report of a Facility ...
10 (2013) 2, S. 99-111: How to secure sustainable competitiveness of Chemical Industry Parks global ...
10 (2013) 3, S. 115-130: Technology transfer by new ventures within the chemical and pharmaceutical ...
10 (2013) 3, S. 131-137: LEAN SCM a paradigm shift in supply chain management
10 (2013) 3, S. 139-149: Optimization of economic conditions in the chemical, pharmaceutical and med...
10 (2013) 3, S. 151-160: Classification of chemicals in the commercial area
11 (2014) 1, S. 3-13: Hidden markets in the chemical industry illusion or growth opportunity?
11 (2014) 1, S. 15-32: Proactive R&D management and information disclosure ramifications for innovat...
11 (2014) 1, S. 33-42: Improving R&D productivity requires a balanced approach
11 (2014) 1, S. 43-50: Bioplastics tipping point drop-in or non-drop-in?
11 (2014) 2, S. 53-66: Impacts of the REACH candidate list of substances subject to authorisation th...
11 (2014) 2, S. 67-76: Practitioner’s Section: Integrated Resource Efficiency Analysis for Reducin...
11 (2014) 2, S. 77-86: Account management 2.0 from silo thinking to integrated account development
11 (2014) 2, S. 87-97: On the current practice of New Business Development in the German chemical in...
12 (2015) 1, S. 3-15: Nanotechnology companies in the United States a web-based content analysis of ...
12 (2015) 1, S. 17-30: Supply Value Management A benchmarking study and a new theoretical approach s...
12 (2015) 1, S. 31-37: Chemical industry activity as a leading indicator of the business cycle
12 (2015) 2, S. 39: 11th anniversary of the Journal of Business Chemistry
12 (2015) 2, S. 41-47: From megatrends to business excellence Managing change in the German chemical...
12 (2015) 2, S. 49-53: Can a top-executive in the chemical industry “survive” without a Business...
12 (2015) 2, S. 55-65: Size does matter in chemical distribution
12 (2015) 3, S. 69-84: Factors influencing organizational change and health evidences from the India...
12 (2015) 3, S. 85-103: The benefits of social sustainability reporting for companies and stakeholde...
12 (2015) 3, S. 105-124: Biomedical research and development in the Indian therapeutic drug industry
12 (2015) 3, S. 117-124: Managing risk during turnarounds and large capital projects experience from...
13 (2016) 1, S. 3-16: Are behavioral pricing tactics also present in the B2B context? evidence from ...
13 (2016) 1, S. 17-32: Critical challenges for SMEs in the UK chemical distribution industry
13 (2016) 1, S. 33-46: Understanding the market dynamics of biosimilars
13 (2016) 1, S. 47-58: PhytoGerm: extraction of germanium from biomass an economic pre-feasibility s...
13 (2016) 2, S. 60-63: Fostering start-ups in the chemical sector through the joint support offered ...
13 (2016) 2, S. 64-79: From customer understanding to product understanding: Collaboration with indu...
13 (2016) 2, S. 80-92: The logistics profile of the German chemical industry
13 (2016) 3, S. 94-98: The focus of the Journal of Business Chemistry: Good management practices in ...
13 (2016) 3, S. 99-101: Managing growth and profitability in the chemical industry Interview with Ha...
13 (2016) 3, S. 102-113: High speed development of new chemical synthesis and materials at molecular...
14 (2017) 1, S. 2-10: Novel approaches in professional education to foster innovation in the chemica...
14 (2017) 1, S. 11-21: The future of German chemical sites: Potential pathways and organizational re...
14 (2017) 1, S. 22-24: Successful management of chemical sites: A challenge for management theory an...
14 (2017) 2, S. 26-28: Digitalization of the chemical industry
14 (2017) 2, S. 29-40: Marketing of chemical parks: Challenges and perspectives
14 (2017) 2, S. 41-50: Design thinking as driver for innovation in the chemical industry
14 (2017) 2, S. 51-64: Implementation of Open Innovation in Chemical B2B Companies
14 (2017) 3, S. 66-72: Brexit and the UK chemical supply chain A commentary on potential effects
14 (2017) 3, S. 73-78: Value pricing in the chemical industry – Rebooted
14 (2017) 3, S. 79-93: Raw Material Excellence in the chemical industry, a game changer turning cost...
14 (2017) 3, S. 94-105: Digitalization in the process industries – Evidence from the German water ...
14 (2017) 3, S. 106-121: Mercury Free UV Lamp for Disinfection and Purification of Drinking, Process...
15 (2018) 1: The road ahead: Digitalization fuels innovation
15 (2018) 1: Business Chemistry: The successful establishment of an interdisciplinary field
15 (2018) 1: Quo vadis Business Chemistry?
15 (2018) 1: Motivation for Innovations - Experiences and Reflections
15 (2018) 1: Chemistry 4.0 - Growth through innovation in a transforming world
15 (2018) 1: Re-inventing chemistry – an industry in transition
15 (2018) 2, S. 56-62: Digitalization, chemical distribution and the chemical value chain
15 (2018) 2, S. 63-70: The digitalization of marketing and sales in the chemical B2B sector
15 (2018) 2, S. 71-77: Successful data applications a cross-industry approach for conceptual plannin...
15 (2018) 2, S. 78-92: Quantitative biology – a perspective for the life sciences' way into the fu...
15 (2018) 3, S. 94-95: Specialty chemicals and contending with forces of change
15 (2018) 3, S. 96-106: Impact of tightened environmental regulation on China´s chemical industry
15 (2018) 3, S. 107-112: The need for diversity in the chemical industry
16 (2019) 1, S. 2-10: The long term survival through innovation
16 (2019) 1, S. 11-25: Managing business model innovation for relocalization in the process and manu...
16 (2019) 1, S. 41-53: Artificial Intelligence in the process industries – technology overview, ca...
16 (2019) 1, S. 54-72: Collaboration in the context of industry convergence - an overview
16 (2019) 1, S. 58-72: Implementation of sustainability in innovation management: The Idea to People...
16 (2019) 2, S. 74-75: Lessons from "Goodbye Hoechst"
16 (2019) 2, S. 76-81: The Digital Revolution is coming to chemical laboratories
16 (2019) 2, S. 82-90: The relation of energy value chains, global GDP and CO2 taxes
16 (2019) 2, S. 91-105: How digital tools make circular economy operational in industrial areas: The...
16 (2019) 2, S. 106-122: Challenges and opportunities in the sustainability of communication devices...
16 (2019) 2, S. 123-133: The smart-up ecosystem: Turning Open Innovation into smart business
16 (2019) 2, S. 134-147: Managing product variety under operational constraints: A process-industria...
16 (2019) 3, S. 149-153: A pulse on the specialty chemical sector
16 (2019) 3, S. 154-164: Challenges affecting the adoption of B2B electronic marketplaces
16 (2019) 3, S. 165-179: A holistic framework and development agenda for accelerated transition towa...
16 (2019) 3, S. 180-197: Commodity price fluctuations and the EROI of oil - How the availability of ...
17 (2020) 1, S. 2-8: Can an artificial intelligence model be the inventor of a molecule designed by ...
17 (2020) 1, S. 9-18: Shaping Digital Sustainable Development in Chemical Companies
17 (2020) 1, S. 20-40: Decarbonization Strategies in Converging Chemical and Energy Markets
17 (2020) 1, S. 41-57: Structuring and managing the new product development process – Review on th...
17 (2020) 1, S. 58-68: Application of Kuhn’s theory of scientific revolution to the theory develop...
17 (2020) 2, S. 70-82: Combine or combust? – Circular economy, digitalization and collaboration mo...
17 (2020) 2, S. 83-108: How to evaluate the future business potential of innovation fields in the ch...
17 (2020) 2, S. 109-130: Sustainability as a criterion for business models – A framework for the l...
17 (2020) 2, S. 131-150: Wealth effects of corporate spin-offs – An event study analysis of the ch...
17 (2020) 2, S. 151-190: User research in pharma R&D: Contextual inquiry for the elicitation of user...
17 (2020) 3, S. 1-16: Innovation and production management in the process industries — An extended...
17 (2020) 3, S. 17-31: Digital transformation in the Swedish process industries: Trends, challenges,...
17 (2020) 3, S. 32-58: Flawless start-up of production plants in process industries: The link betwee...
17 (2020) 3, S. 59-80: Success factors for intra-firm process technology transfer, and a petrochemic...
17 (2020) 3, S. 81-109: Supporting start-ups in the process industries with accelerator programs: Ty...
17 (2020) 3, S. 110-123: Start-ups as an indicator of early market convergence
18 (2021) 1, S. 2-8: Reducing the emissions Scope 1-3 in the chemical industry
18 (2021) 1, S. 9-19: The Strategic Approach to International Chemicals Management: A case study of ...
18 (2021) 1, S. 20-42: When data science meets patent information – Analyzing complex business env...
18 (2021) 2, S. 44-48: Sustainability in Uncertainty?
18 (2021) 2, S. 49-62: Validating the Product-Market-Fit of a B2B Platform Venture with a Minimum Vi...
18 (2021) 2, S. 63-78: Options for CO2-neutral production of bulk chemicals
18 (2021) 3, S. 80-95: Carbon Capture and Utilization – A new building block for Circular Economy?
18 (2021) 3, S. 96-104: Is the EU Green Deal channelling a transition towards a sustainable chemical...
18 (2021) 3, S. 105-108: Disruption of the role model closed loop mechanical recycling of PET
19 (2022) 1, S. 2-18: Joint Product Analysis of Rare Earths: Economic, Market and Technological Insi...
19 (2022) 1, S. 19-29: The Influence of Market Orientation on Innovativeness
19 (2022) 1, S. 30-35: Gender – an essential substance for sustainable chemistry
19 (2022) 1, S. 36-38: Better Batteries – Better Recycling?
19 (2022) 1, S. 39-43: My personal view on investment in chemistry start-ups
19 (2022) 2, S. 45-57: An exploration of the ankle-biters and their role in business ecosystems
19 (2022) 2, S. 58-72: Product footprint reporting for chemical companies
19 (2022) 2, S. 73-79: After COVID, What’s Next for Pharma Supply Chains?
19 (2022) 3, S. 81-99: Improvising in a crisis: an empirical study of NPD teams in the field of chem...
19 (2022) 3, S. 100-109: How chemicals can serve people sustainably without polluting the planet: th...
19 (2022) 3, S. 110-115: Cradle to Cradle: Why we need to rethink the way we produce
19 (2022) 3, S. 116-122: Current trends and challenges in the pharmaceutical industry – we are her...
20 (2023) 1, S. 9-30: Innovation methodologies and Design Thinking as supporting instruments in the ...
20 (2023) 1, S. 31-45: A review on influence factors promoting or inhibiting the transfer of researc...
20 (2023) 1, S. 46-59: The Northern Netherlands: Transformation of a gas-producing region into a for...
20 (2023) 1, S. 60-74: Ecosystem for Greentech start-ups in the Rhine-Main-Neckar metropolitan area ...
20 (2023) 2, S. 75-86: Transform the European process industries: A multi-level perspective
20 (2023) 2, S. 87-111: Exploring sustainability integration and expected outcomes of a digitalized ...
20 (2023) 2, S. 112-122: DATA – a sustainable performance accounting framework for SMEs. From macr...
20 (2023) 2, S. 123-128: The chemical industry as a key player for climate protection: Learning expe...
20 (2023) 2, S. 129-135: Sustainable industrial area management: Using the materiality analysis at a...
20 (2023) 2, S. 136-140: The role of hydrogen in the process industries – implications on energy i...
20 (2023) 2, S. 141-144: Responsible Use – The Social License-to-Operate A business approach towar...
20 (2023) 2, S. 145-150: Turning point(s) (“Zeitenwende”) and new multipolarity: Is the industry...
20 (2023) 2, S. 151-155: An active systemic industrial policy for climate-neutral process industries...
20 (2023) 3, S. 157-165: Building bridges in education: Exploring how engineering and MBA students c...
20 (2023) 3, S. 166-170: Intercultural leadership – A need for now and the future in chemical indu...
20 (2023) 3, S. 171-172: Book review – Chemistry Entrepreneurship
21 (2024) 1, S. 2-27: Structural analysis of petrochemical clusters in Germany: What can be learned ...
21 (2024) 1, S. 28-41: A catalyst for change? How sustainable finance can support the transition of ...
21 (2024) 1, S. 42-44: How to Enable the Transition From Fossil to Renewable Carbon in the Chemical ...

Procurement in 21st century in the chemical, pharmaceutical and healthcare industry

Ähnliche Einträge